MELROSE PARK, Ill., Nov. 1, 2010 /PRNewswire-FirstCall/ -- Alberto Culver Company (NYSE: ACV), a leading manufacturer and marketer of beauty care brands including TRESemme, Alberto VO5, Nexxus, St. Ives, Simple and Noxzema, today announced results for its fourth quarter and fiscal year 2010 ended September 30, 2010.

Fourth Quarter


    --  Net sales for the fourth quarter increased 12.1% to $431.9 million
        compared to $385.2 million in the prior year quarter.  On an organic
        basis, which excludes the effect of foreign currency fluctuations and
        acquisitions and divestitures, sales increased 4.9% in the current
        quarter.
    --  Diluted earnings per share from continuing operations increased 28.1% to
        41 cents in the fourth quarter compared to 32 cents in the prior year
        quarter.  Excluding restructuring and discrete items, diluted earnings
        per share from continuing operations increased 39.4% to 46 cents
        compared to 33 cents in the prior year quarter.
        --  The current and prior year quarters include approximately 4 cents
            per share and 3 cents per share, respectively, of tax benefits
            resulting from intercompany dividend payments.

Fiscal Year


    --  Net sales for the fiscal year increased 11.4% to $1.60 billion compared
        to $1.43 billion in the prior year period.  On an organic basis, which
        excludes the effect of foreign currency fluctuations and acquisitions
        and divestitures, sales increased 4.2% in the current fiscal year.
    --  Diluted earnings per share from continuing operations increased 30.3% to
        $1.55 in fiscal year 2010 compared to $1.19 in the prior year period. 
        Excluding restructuring and discrete items, diluted earnings per share
        from continuing operations increased 22.7% to $1.62 compared to $1.32 in
        the prior year period.
        --  The current year includes approximately 4 cents per share of tax
            benefits resulting from intercompany dividend payments offset by
            approximately 4 cents per share of expenses related to the voluntary
            withdrawal of select products in the Company's relaxer kit business.
        --  The prior year includes approximately 3 cents per share of tax
            benefits resulting from intercompany dividend payments.

In the U.S., sales increased 3.5% in the fourth quarter due to growth in TRESemme and Nexxus. International sales on a reported basis increased 26.7% (the net effect of foreign currency fluctuations, acquisitions and divestitures accounted for approximately 19.5% of the growth) as each international region generated organic sales growth, with Latin America and Canada being particularly strong.

The Company's gross profit margin was 52.1% in the fourth quarter compared to 52.3% in the prior year quarter. The decrease in gross margin was primarily a result of elevated trade promotions, partly offset by manufacturing efficiencies. For the full fiscal year 2010, gross profit margin improved 100 basis points to 52.3% compared to 51.3% in the prior year mainly due to lower commodity costs, partially offset by higher trade promotions.

Advertising and other marketing investments in the fourth quarter were $74.6 million. For the full fiscal year 2010, advertising and other marketing investments increased 9.3% to $261.8 million compared to the prior year.

Selling and administrative expenses as a percentage of net sales decreased 30 basis points to 20.3% in the fourth quarter compared to 20.6% in the prior year quarter. For the full fiscal year 2010, selling and administrative expenses as a percentage of net sales decreased 40 basis points to 20.9% compared to 21.3% in the prior year.

Carol Lavin Bernick, Executive Chairman of the Company, announced that the Company's board of directors approved the regular 8.5 cents quarterly cash dividend. The dividend will be paid on November 23, 2010 to shareholders of record on November 11, 2010.

On September 27, 2010, the Company entered into a definitive agreement with Unilever pursuant to which Unilever will acquire all of the outstanding shares of Alberto Culver for $37.50 per share in cash, valuing the company at approximately $3.7 billion. The transaction is structured as a merger and is subject to approval by owners holding a majority of Alberto Culver's outstanding common stock, regulatory approvals and other customary closing conditions. The merger agreement was unanimously approved by the Boards of Directors of both companies.

On December 18, 2009, the Company completed the acquisition of all of the issued and outstanding shares of Simple Health & Beauty Group Limited. Simple is a leading skin care company based in the United Kingdom that was owned primarily by Duke Street, a mid-market private equity fund. The total purchase price was approximately $385 million, and the transaction was funded from the Company's existing cash.

On July 31, 2008, the Company sold its Cederroth International subsidiary to a company owned by two funds controlled by CapMan, a Nordic based private equity firm, for 159.5 million Euros. As a result of the transaction, the results of operations of Cederroth are reported as discontinued operations.

On November 16, 2006, the Company closed a transaction that separated its consumer products business from its beauty supply distribution business and resulted in the formation of two separate and independent publicly-traded companies: new Alberto Culver and Sally Beauty Holdings, Inc. As a result of the transaction, the results of operations of the beauty supply distribution business are reported as discontinued operations.

Due to the disclosure of organic sales growth and financial results excluding restructuring and discrete items, this press release contains certain non-GAAP financial measures as defined by Regulation G of the Securities and Exchange Commission. A description of the Company's restructuring activities and discrete items, as well as a reconciliation of non-GAAP financial measures to the most directly comparable GAAP measures, are included as a schedule to this release and can also be found on the Company's web site at www.alberto.com.

Alberto Culver Company manufactures, distributes and markets leading beauty care and other personal care brands including TRESemme, Alberto VO5, Nexxus, St. Ives, Simple and Noxzema in the United States and internationally. It is also the second largest producer in the U.S. of products for the ethnic hair care market with leading brands including Motions and Soft & Beautiful. Several of its household/grocery brands such as Mrs. Dash and Static Guard are niche category leaders in the U.S.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and assessments of risks and uncertainties and reflect various assumptions concerning anticipated results, which may or may not prove to be correct. Some of the factors relating to the Unilever merger that could cause actual results to differ materially from estimates or projections contained in such forward-looking statements include: the occurrence of any event, effect or change that could give rise to a termination of the Unilever merger agreement; the outcome of legal proceedings that have been instituted or may be instituted in the future against the Company in connection with the Unilever merger agreement; the inability to complete the Unilever merger due to the failure to obtain stockholder approval or the failure to satisfy other conditions to the completion of the merger, including the receipt of certain regulatory approvals; risks that the proposed transaction disrupts current plans and operations and creates potential difficulties in employee retention; and the amount of the costs, fees, expenses and charges related to the Unilever merger. Other factors not involving the Unilever merger that could cause actual results to differ materially from estimates or projections contained in such forward-looking statements include: the pattern of brand sales; competition within the relevant product markets; loss of one or more key customers; inability of efficiency initiatives to improve the Company's margins; loss of one or more key suppliers or copackers; inability of the Company to protect its intellectual property; the disruption of normal business activities due to the Company's implementation of a new worldwide ERP system; manufacturing and supply chain disruptions; adverse changes in currency exchange rates; special demands by key customers; risks inherent in acquisitions, divestitures and strategic alliances, including, without limitation, undisclosed liabilities and obligations for which the Company may have limited or no recourse; loss of one or more key employees; risks inherent in expanding in existing geographic locations and entering new geographic locations; the risk that the expected cost savings related to the reorganizations and restructurings may not be realized; the effects of a prolonged United States or global economic downturn or recession; health epidemics; unavailability of raw materials or finished products; increases in costs of raw materials and inflation rates; events that negatively affect the intended tax free nature of the distribution of shares of Alberto Culver Company in connection with the separation of the consumer products business from the beauty supply distribution business on November 16, 2006; changes in costs; the unanticipated costs and effects of legal or administrative proceedings; adverse weather conditions; and variations in political, economic or other factors such as interest rates, availability of credit, tax changes, legal and regulatory changes or other external factors over which the Company has no control. These forward-looking statements speak only as of the date of this press release, and there is no undertaking to update or revise them as more information becomes available. Additional factors that could cause Alberto Culver's results to differ materially from those described in the forward-looking statements can be found in the Company's 2009 Annual Report on Form 10-K filed on November 24, 2009 with the SEC and available at the SEC's internet site (http://www.sec.gov). In addition, please refer to the documents that the Company files with the SEC on Forms 10-Q and 8-K, which identify and address other important factors that could cause events and results to differ materially from those contained in the forward-looking statements set forth in this press release.

Additional Information About the Merger and Where to Find It

Alberto Culver Company filed a preliminary proxy statement with the SEC on Friday, October 15, 2010. A definitive proxy statement will also be filed with the SEC. Stockholders are urged to read the definitive proxy statement and other relevant materials when they become available because they will contain important information about the proposed transaction with Unilever. The definitive proxy statement will be mailed or delivered to the Company's stockholders. In addition, stockholders will be able to obtain the proxy statement and other relevant documents filed by the Company with the SEC free of charge at the SEC's website at www.sec.gov, at the Company's website at www.alberto.com/investing by clicking on the link "SEC Filings" or from Alberto Culver Company, Attention: Investor Relations, 2525 Armitage Avenue, Melrose Park, Illinois 60160, (708) 450-3000.

Participants in the Solicitation

The Company and its directors and executive officers may be deemed to be participants in the solicitation of proxies from the stockholders of the Company in connection with the proposed transaction with Unilever. Information about the Company and its directors and executive officers, and their ownership of the Company's securities, is set forth in the proxy statement for the annual meeting of stockholders of the Company held on January 28, 2010, which was filed with the SEC on December 14, 2009. Additional information regarding the interests of those persons may be obtained by reading the preliminary proxy statement filed with the SEC on Friday, October 15, 2010.



    Consolidated Condensed Statements of Earnings (Unaudited)
    (in thousands, except per share data)
    -------------------------------------


    Three Months Ended
     September 30, 2010 and
     2009                            2010        2009
    -----------------------          ----        ----

    Net sales                    $431,882     385,191
    Cost of products sold         206,959     183,845
                                  -------     -------
      Gross profit                224,923     201,346
    Advertising, marketing,
     selling and administrative   162,251     155,533
    Transaction expenses (1)        7,279          --
    Restructuring and other (2)       381       1,464
                                      ---       -----
      Operating earnings           55,012      44,349
    Interest expense (income),
     net                            1,793        (345)
                                    -----        ----
    Earnings from continuing
     operations before income
     taxes                         53,219      44,694
    Provision for income taxes
     (3)                           11,906      13,309
                                   ------      ------
    Earnings from continuing
     operations                    41,313      31,385
    Discontinued operations,
     net of income taxes (4)           36         278
                                      ---         ---
    Net earnings                  $41,349      31,663
                                  =======      ======

    Basic earnings per share:
      Continuing operations          $.42         .32
      Discontinued operations          --          --
                                      ---         ---
      Total                          $.42         .32
                                     ====         ===

    Diluted earnings per share:
      Continuing operations (1)
       (2) (3)                       $.41         .32
      Discontinued operations          --          --
                                      ---         ---
      Total                          $.41         .32
                                     ====         ===

    Weighted average shares
     outstanding:
      Basic                        98,216      97,721
      Diluted                     100,271      99,402



              Transaction expenses reflect investment banking, legal
              and other professional service fees incurred in
              connection with the proposed transaction with
              Unilever.  During the fourth quarter of fiscal year
              2010, this amount reduced earnings from continuing
              operations by $7,279 and diluted earnings per share
    (1)       from continuing operations by 7 cents.
              Restructuring and other primarily includes severance
              and other costs incurred in connection with the
              Company's plan to downsize its manufacturing facility
              and consolidate its warehouse and office facilities
              in Chatsworth, California, which was announced in
              June 2009, and the Company's subsequent plan
              primarily related to ceasing all manufacturing
              activities at its Chatsworth facility, which was
              announced in November 2009.  During the fourth
              quarter of fiscal year 2010, restructuring and other
              reduced earnings from continuing operations (net of
              tax) by $309 and did not have an effect on diluted
              earnings per share from continuing operations.
              During the fourth quarter of fiscal year 2009,
              restructuring and other reduced earnings from
              continuing operations (net of tax) by $943 and
              diluted earnings per share from continuing operations
    (2)       by 1 cent.
              The provision for income taxes in the fourth quarter
              of fiscal year 2010 includes $2,431 of discrete tax
              benefit, which increased diluted earnings per share
              from continuing operations by 2 cents.  The provision
              for income taxes in the fourth quarter of fiscal year
              2009 includes $288 of discrete tax expense, which did
              not have an effect on diluted earnings per share from
    (3)       continuing operations.
              Discontinued operations in the fourth quarter of both
              fiscal years 2010 and 2009 include adjustments to
              self-insurance reserves for pre-separation Sally
    (4)       claims retained by Alberto Culver.


    Consolidated Condensed Statements of Earnings (Unaudited)
    (in thousands, except per share data)
    -------------------------------------


    Twelve Months Ended September 30,
     2010 and 2009                                2010          2009
    ---------------------------------             ----          ----

    Net sales                               $1,597,233     1,433,980
    Cost of products sold                      762,557       698,778
                                               -------       -------
         Gross profit                          834,676       735,202
    Advertising, marketing, selling and
     administrative (1)                        596,124       545,261
    Transaction expenses (2)                    13,283            --
    Restructuring and other (3)                  5,101         6,776
                                                 -----         -----
         Operating earnings                    220,168       183,165
    Interest expense (income), net               2,324        (2,673)
                                                 -----        ------
    Earnings from continuing operations
     before income taxes                       217,844       185,838
    Provision for income taxes (4)              62,708        68,005
                                                ------        ------
    Earnings from continuing operations        155,136       117,833
    Discontinued operations, net of
     income taxes (5)                              174         1,541
                                                   ---         -----
    Net earnings                              $155,310       119,374
                                              ========       =======

    Basic earnings per share:
         Continuing operations                   $1.58          1.21
         Discontinued operations                   .01           .01
                                                   ---           ---
         Total                                   $1.59          1.22
                                                 -----          ----

    Diluted earnings per share:
         Continuing operations (2) (3) (4)       $1.55          1.19
         Discontinued operations                   .01           .01
                                                   ---           ---
         Total                                   $1.56          1.20
                                                 =====          ====

    Weighted average shares outstanding:
         Basic                                  97,985        97,670
         Diluted                                99,852        99,108



              Fiscal year 2010 includes $5,490 of expenses related to
              the withdrawal of select products in the Company's
              relaxer kit business and $7,615 of earnings from the
              settlement of a dispute with a supplier.  Fiscal year
              2009 includes $2,933 of expenses related to the same
    (1)       dispute with a supplier.
              Transaction expenses reflect investment banking, legal
              and other professional service fees incurred in
              connection with the proposed transaction with Unilever
              ($7,279) and the acquisition of Simple Health & Beauty
              Group Limited ($6,004).  During fiscal year 2010, this
              amount reduced earnings from continuing operations by
              $13,283 and diluted earnings per share from continuing
    (2)       operations by 13 cents.
              Restructuring and other primarily includes severance
              and other costs incurred related to the Company's plan
              to downsize its manufacturing facility and consolidate
              its warehouse and office facilities in Chatsworth,
              California, which was announced in June 2009, and the
              Company's subsequent plan primarily related to ceasing
              all manufacturing activities at its Chatsworth
              facility, which was announced in November 2009.
              During fiscal year 2010, restructuring and other
              reduced earnings from continuing operations (net of
              tax) by $3,224 and diluted earnings per share from
              continuing operations by 3 cents. During fiscal year
              2009, restructuring and other reduced earnings from
              continuing operations (net of tax) by $4,234 and
              diluted earnings per share from continuing operations
    (3)       by 4 cents.
              The provision for income taxes in fiscal year 2010
              includes $4,542 of discrete tax benefit, which
              increased diluted earnings per share from continuing
              operations by 4 cents.  The provision for income taxes
              in fiscal year 2009 includes $6,813 of discrete tax
              expense, primarily related to taxes on a local
              currency gain on U.S. dollar denominated cash held in
              Sweden following the Cederroth sale, which reduced
              diluted earnings per share from continuing operations
    (4)       by 7 cents.
              Discontinued operations in both periods include
              adjustments to self-insurance reserves for pre-
              separation Sally claims retained by Alberto Culver.
              In fiscal year 2009, discontinued operations also
    (5)       include adjustments related to the sale of Cederroth.


    Consolidated Condensed Balance Sheets (Unaudited)
    (in thousands)
    --------------


                                          September 30,
    Assets                                 2010           2009
                                           ----           ----
    Cash and cash equivalents          $301,978        469,775
    Accounts receivable, net            283,183        228,979
    Inventories                         171,306        126,777
    Other current assets and
     income taxes                        47,637         40,097
                                         ------         ------
         Total current assets           804,104        865,628
    Property, plant and
     equipment, net                     247,049        249,911
    Goodwill and trade names            688,715        313,955
    Long-term investments                53,706         58,412
    Other assets                         84,701         70,108
                                         ------         ------
         Total assets                $1,878,275      1,558,014
                                     ==========      =========

    Liabilities and Stockholders'
     Equity
    Current portion of long-term
     debt                                  $181            175
    Accounts payable, accrued
     expenses and income taxes          283,243        275,649
                                        -------        -------
         Total current liabilities      283,424        275,824
    Long-term debt                      150,241            429
    Other liabilities and income
     taxes                              117,370         80,339
                                        -------         ------
         Total liabilities              551,035        356,592
    Stock options subject to
     redemption                           2,628          4,776
    Stockholders' equity              1,324,612      1,196,646
                                      ---------      ---------
         Total liabilities and
          stockholders' equity       $1,878,275      1,558,014
                                     ==========      =========


                 Segment Data (Unaudited)
    (in thousands)
    --------------


    Three Months Ended September
     30, 2010 and 2009                    2010           2009
    ----------------------------          ----           ----

    Net Sales:
    United States                     $250,760        242,263
    International                      181,122        142,928
                                       -------        -------
                                      $431,882        385,191
                                      ========        =======

    Earnings From Continuing
     Operations Before Income
     Taxes:
    United States                      $39,255         37,646
    International                       26,757         10,444
                                        ------         ------
    Segment operating profit            66,012         48,090
    Stock-based compensation
     expense                            (3,340)        (2,277)
    Transaction expenses (1)            (7,279)            --
    Restructuring and other (2)           (381)        (1,464)
    Interest income (expense),
     net                                (1,793)           345
                                        ------            ---
                                       $53,219         44,694
                                       =======         ======

    Twelve Months Ended September
     30, 2010 and 2009                    2010           2009
    -----------------------------         ----           ----

    Net Sales:
    United States                     $943,916        916,996
    International                      653,317        516,984
                                       -------        -------
                                    $1,597,233      1,433,980
                                    ==========      =========

    Earnings From Continuing
     Operations Before Income
     Taxes:
    United States                     $161,900        153,192
    International                       89,465         47,249
                                        ------         ------
    Segment operating profit           251,365        200,441
    Stock-based compensation
     expense                           (12,813)       (10,500)
    Transaction expenses (1)           (13,283)            --
    Restructuring and other (2)         (5,101)        (6,776)
    Interest income (expense),
     net                                (2,324)         2,673
                                        ------          -----
                                      $217,844        185,838
                                      ========        =======



          Transaction expenses reflect investment banking, legal and other
          professional service fees incurred in connection with the
          proposed transaction with Unilever and the acquisition of
    (1)   Simple Health & Beauty Group Limited.
          Restructuring and other primarily includes severance and other
          costs incurred related to the Company's plan to downsize its
          manufacturing facility and consolidate its warehouse and office
          facilities in Chatsworth, California, which was announced in
          June 2009, and the Company's subsequent plan primarily related
          to ceasing all manufacturing activities at its Chatsworth
    (2)   facility, which was announced in November 2009.

Schedule - Reconciliation of Non-GAAP Financial Measures

The Company's press release announcing results of operations for the three and twelve months ended September 30, 2010 includes references to certain of the following "non-GAAP financial measures" as defined by Regulation G of the Securities and Exchange Commission:


    --  Pre-tax earnings from continuing operations excluding restructuring and
        discrete items
    --  Earnings from continuing operations excluding restructuring and discrete
        items
    --  Diluted earnings per share from continuing operations excluding
        restructuring and discrete items
    --  Organic sales growth

In June 2009, the Company committed to a plan primarily related to the downsizing of its manufacturing facility and the consolidation of its warehouse and office facilities in Chatsworth, California. During fiscal year 2009, the Company recorded restructuring costs related to this plan of $6.3 million ($1.3 million in the fourth quarter). During fiscal year 2010, the Company recorded additional restructuring costs related to this plan of $460,000 ($81,000 in the fourth quarter).

In November 2009, the Company committed to a plan primarily related to ceasing all manufacturing activities at its facility in Chatsworth, California. This plan is in addition to the Company's initial plan to downsize the Chatsworth manufacturing facility. During fiscal year 2010, the Company recorded restructuring costs related to this plan of $4.5 million ($98,000 in the fourth quarter), primarily related to severance.

In addition to these two plans, the Company recorded restructuring costs of $119,000 in fiscal year 2010 ($202,000 in the fourth quarter) and $519,000 during fiscal year 2009 ($117,000 in the fourth quarter) related to previously announced plans.

In total, the Company recorded restructuring and other costs during fiscal year 2010 of $5.1 million ($3.2 million after taxes or 3 cents per diluted share from continuing operations) with $381,000 in the fourth quarter ($309,000 after taxes and no effect on diluted earnings per share from continuing operations). In fiscal year 2009, the Company recorded total restructuring and other costs of $6.8 million ($4.2 million after taxes or 4 cents per diluted share from continuing operations) with $1.5 million in the fourth quarter ($943,000 after taxes or 1 cent per diluted share from continuing operations).

In connection with the proposed transaction with Unilever, the Company incurred transaction expenses (primarily investment banking, legal and other professional service fees) during the fourth quarter of fiscal year 2010 of $7.3 million (7 cents per diluted share from continuing operations). In connection with the acquisition of Simple Health & Beauty Group Limited on December 18, 2009, the Company incurred transaction expenses during fiscal year 2010 of $6.0 million (6 cents per diluted share from continuing operations). In total, the Company incurred transaction expenses of $13.3 million (13 cents per diluted share from continuing operations) with $7.3 million in the fourth quarter (7 cents per diluted share from continuing operations). These amounts are not expected to be deductible for income tax purposes.

In fiscal year 2009, the Company incurred costs related to a dispute with a supplier of $2.9 million ($1.9 million after taxes) with $278,000 in the fourth quarter ($186,000 after taxes). In fiscal year 2010, additional costs of $1.1 million were incurred prior to the dispute being settled in the third quarter. The settlement included the forgiveness of $5.8 million of obligations the Company owed to the supplier and the receipt of $2.9 million in cash from the supplier. On a net basis, the Company recorded a benefit related to this matter of $7.6 million in fiscal year 2010 ($5.2 million after taxes or 5 cents per diluted share from continuing operations).

The Company's provision for income taxes in fiscal year 2010 included net discrete tax benefit of $4.5 million (4 cents per diluted share from continuing operations) with net discrete tax benefit of $2.4 million in the fourth quarter (2 cents per diluted share from continuing operations). The Company's provision for income taxes in fiscal year 2009 included net discrete tax expense of $6.8 million (7 cents per diluted share from continuing operations), with $288,000 in the fourth quarter. The fiscal year 2009 amount is primarily related to taxes on a local currency gain on U.S. dollar denominated cash held in Sweden following the Cederroth sale.



         Schedule - Reconciliation of Non-GAAP Financial Measures
                                (continued)
         --------------------------------------------------------
    Reconciliations of these non-GAAP financial measures to their most
    directly comparable financial measures
    under GAAP for the three and twelve months ended September 30, 2010
    and 2009 are as follows (in thousands,
    except per share data):


                             Three Months Ended        Twelve Months Ended
                                September 30               September 30
                            2010        2009         2010             2009
                            ----        ----         ----             ----
    Pre-tax earnings
     from continuing
     operations, as
     reported            $53,219      44,694     $217,844          185,838
    Restructuring and
     other                   381       1,464        5,101            6,776
    Transaction
     expenses              7,279          --       13,283               --
    Dispute with a
     supplier                 --         278       (7,615)           2,933
                             ---         ---       ------            -----
    Pre-tax earnings
     from continuing
     operations,
     excluding
       restructuring and
        discrete items   $60,879      46,436     $228,613          195,547
                         =======      ======     ========          =======

    Earnings from
     continuing
     operations (net
     of income
     taxes),
       as reported       $41,313      31,385     $155,136          117,833
    Restructuring and
     other, net of
     income taxes            309         943        3,224            4,234
    Transaction
     expenses, net of
     income taxes          7,279          --       13,283               --
    Dispute with a
     supplier, net of
     income taxes             --         186       (5,224)           1,930
    Discrete tax
     items               (2,431)         288       (4,542)           6,813
                          ------         ---       ------            -----
    Earnings from
     continuing
     operations (net
     of income
     taxes),
       excluding
        restructuring
        and discrete
        items            $46,470      32,802     $161,877          130,810
                         =======      ======     ========          =======

    Diluted earnings
     per share from
     continuing
     operations,
       as reported          $.41         .32        $1.55             1.19
    Restructuring and
     other, net of
     income taxes             --         .01          .03              .04
    Transaction
     expenses, net of
     income taxes            .07          --          .13               --
    Dispute with a
     supplier, net of
     income taxes             --          --         (.05)             .02
    Discrete tax
     items                  (.02)         --         (.04)             .07
                            ----         ---         ----              ---
    Diluted earnings
     per share from
     continuing
     operations,
       excluding
        restructuring
        and discrete
        items               $.46         .33        $1.62             1.32
                            ====         ===        =====             ====

                          Three Months Ended    Twelve Months Ended
                              September 30          September 30
                            2010        2009         2010             2009
                            ----        ----         ----             ----
    Net sales growth
     (decline), as
     reported               12.1%      (0.2)%        11.4%           (0.7)%
    Effect of foreign
     currency
     fluctuations           (0.1)        5.0         (2.1)             8.1
    Effect of
     acquisition            (7.6)       (2.6)        (5.8)            (2.5)
    Effect of
     divestiture             0.5         0.5          0.7              0.1
                             ---         ---          ---              ---
    Organic sales
     growth                  4.9%        2.7%         4.2%             5.0%
                             ===         ===          ===              ===

Management uses these non-GAAP financial measures to evaluate the performance of the Company and believes the presentation of these amounts provides the reader with information necessary to analyze the Company's normal operations for the periods compared.

SOURCE Alberto Culver Company